Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease

M. Hajsl, A. Hlavackova, K. Broulikova, M. Sramek, M. Maly, JE. Dyr, J. Suttnar,

. 2020 ; 10 (5) : . [pub] 20200519

Language English Country Switzerland

Document type Journal Article

Grant support
NV18-08-00149 Czech health research council
CZ.02.1.01/0.0/0.0/16_025/0007428, OP RDE European Regional Development Fund and the state budget of the Czech Republic
00023736 Project of the Ministry of Health, Czech Republic
1011 Long-term organization development plan, Faculty of Military Health Sciences, Hradec Kralove

Atherosclerosis is a leading cause of major vascular events, myocardial infarction, and ischemic stroke. Tryptophan (TRP) catabolism was recognized as an important player in inflammation and immune response having together with oxidative stress (OS) significant effects on each phase of atherosclerosis. The aim of the study is to analyze the relationship of plasma levels of TRP metabolites, inflammation, and OS in patients with neurovascular diseases (acute ischemic stroke (AIS), significant carotid artery stenosis (SCAS)) and in healthy controls. Blood samples were collected from 43 patients (25 with SCAS, 18 with AIS) and from 25 healthy controls. The concentrations of twelve TRP metabolites, riboflavin, neopterin (NEO, marker of inflammation), and malondialdehyde (MDA, marker of OS) were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Concentrations of seven TRP metabolites (TRP, kynurenine (KYN), 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-HAA), anthranilic acid (AA), melatonin (MEL), tryptamine (TA)), NEO, and MDA were significantly different in the studied groups. Significantly lower concentrations of TRP, KYN, 3-HAA, MEL, TA, and higher MDA concentrations were found in AIS compared to SCAS patients. MDA concentration was higher in both AIS and SCAS group (p < 0.001, p = 0.004, respectively) compared to controls, NEO concentration was enhanced (p < 0.003) in AIS. MDA did not directly correlate with TRP metabolites in the study groups, except for 1) a negative correlation with kynurenine acid and 2) the activity of kynurenine aminotransferase in AIS patients (r = -0.552, p = 0.018; r = -0.504, p = 0.033, respectively). In summary, TRP metabolism is clearly more deregulated in AIS compared to SCAS patients; the effect of TRP metabolites on OS should be further elucidated.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20019179
003      
CZ-PrNML
005      
20201123123915.0
007      
ta
008      
201103s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/metabo10050208 $2 doi
035    __
$a (PubMed)32438592
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hajsl, Martin $u Department of Medicine, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic. Department of Military Internal Medicine and Military Hygiene, Faculty of Military Health Sciences, University of Defence, 50002 Hradec Kralove, Czech Republic.
245    10
$a Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease / $c M. Hajsl, A. Hlavackova, K. Broulikova, M. Sramek, M. Maly, JE. Dyr, J. Suttnar,
520    9_
$a Atherosclerosis is a leading cause of major vascular events, myocardial infarction, and ischemic stroke. Tryptophan (TRP) catabolism was recognized as an important player in inflammation and immune response having together with oxidative stress (OS) significant effects on each phase of atherosclerosis. The aim of the study is to analyze the relationship of plasma levels of TRP metabolites, inflammation, and OS in patients with neurovascular diseases (acute ischemic stroke (AIS), significant carotid artery stenosis (SCAS)) and in healthy controls. Blood samples were collected from 43 patients (25 with SCAS, 18 with AIS) and from 25 healthy controls. The concentrations of twelve TRP metabolites, riboflavin, neopterin (NEO, marker of inflammation), and malondialdehyde (MDA, marker of OS) were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Concentrations of seven TRP metabolites (TRP, kynurenine (KYN), 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-HAA), anthranilic acid (AA), melatonin (MEL), tryptamine (TA)), NEO, and MDA were significantly different in the studied groups. Significantly lower concentrations of TRP, KYN, 3-HAA, MEL, TA, and higher MDA concentrations were found in AIS compared to SCAS patients. MDA concentration was higher in both AIS and SCAS group (p < 0.001, p = 0.004, respectively) compared to controls, NEO concentration was enhanced (p < 0.003) in AIS. MDA did not directly correlate with TRP metabolites in the study groups, except for 1) a negative correlation with kynurenine acid and 2) the activity of kynurenine aminotransferase in AIS patients (r = -0.552, p = 0.018; r = -0.504, p = 0.033, respectively). In summary, TRP metabolism is clearly more deregulated in AIS compared to SCAS patients; the effect of TRP metabolites on OS should be further elucidated.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hlavackova, Alzbeta $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 12820 Prague, Czech Republic.
700    1_
$a Broulikova, Karolina $u Department of Medicine, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic. Department of Military Internal Medicine and Military Hygiene, Faculty of Military Health Sciences, University of Defence, 50002 Hradec Kralove, Czech Republic.
700    1_
$a Sramek, Martin $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic.
700    1_
$a Maly, Martin $u Department of Medicine, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic.
700    1_
$a Dyr, Jan E $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 12820 Prague, Czech Republic.
700    1_
$a Suttnar, Jiri $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 12820 Prague, Czech Republic.
773    0_
$w MED00193532 $t Metabolites $x 2218-1989 $g Roč. 10, č. 5 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32438592 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201103 $b ABA008
991    __
$a 20201123123914 $b ABA008
999    __
$a ind $b bmc $g 1585959 $s 1109377
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 5 $e 20200519 $i 2218-1989 $m Metabolites $n Metabolites $x MED00193532
GRA    __
$a NV18-08-00149 $p Czech health research council
GRA    __
$a CZ.02.1.01/0.0/0.0/16_025/0007428, OP RDE $p European Regional Development Fund and the state budget of the Czech Republic
GRA    __
$a 00023736 $p Project of the Ministry of Health, Czech Republic
GRA    __
$a 1011 $p Long-term organization development plan, Faculty of Military Health Sciences, Hradec Kralove
LZP    __
$a Pubmed-20201103

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...